Arimidex: Compliance and arthralgias in clinical therapy (COMPACT) - COMPACT

Study identifier:NIS-ODE-ARI-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Arimidex: Compliance and arthralgias in clinical therapy (COMPACT): An in practice assessment of arthralgias and related costs as well as compliance in the first year of anastrozole therapy

Medical condition

Breast Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

2313

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Apr 2009
Primary Completion Date: -
Study Completion Date: 01 Feb 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria